TULA® - Trans Urethral Laser Ablation of Recurring Bladder Tumors

The ability of simultaneous vaporization and coagulation offers a simple and safe method with a minimal to non loss of blood. The laser procedure can be performed on an outpatient basis under local anesthesia or even without anesthesia and offers the advantage over the previous standard procedure that general anesthesia can be omitted.

Non-muscle invasive bladder tumor normally has a high recurrence rate, leading to multiple treatments. Elderly patients with multiple morbidities are not fit for conventional treatment under general anesthesia. TULA® DUAL offers a technique using flexible cystoscopy for the treatment of bladder tumor under local or even no anesthesia in outpatient settings.




biolitec is present at congresses and other important events worldwide. Here is an overview:


Postponed from 26.04.-29.04.2020

11th ECIO - European Conference on Interventional Oncology
in Nice, France
03.11.2020 International TULA® Laser Workshop for Non-Muscle-Invasive Bladder Tumors
St Peters Hospital, Guildford Road, London – Department of Urology, Dr. S. Agrawal
Please register at haris.dulic@biolitec.com
Max. 4 participants
More information can be found here.
16.11.-19.11.2020 Medica 2020, Hall 10 Booth H46
in Dusseldorf, Germany
04.02.-05.02.2021 ESU-ESOU Masterclass on Non-Muscle Invasive Bladder Cancer
in Prague

Laser Safety Course biolitec
Speaker: Dr. Roland Dreschau, CeramOptec GmbH
Attendance fee: € 295,- zzgl. MwSt.
Event location: biolitec biomedical technology GmbH, Brühler Str. 30, 53119 Bonn
Registration: iris.walterscheid@biolitec.com

Postponed to 09.07.-13.07.2021
21st EAU - European Association of Urology Congress
in Milan, Italy